Description
Contents
Meningococcal polysaccharide serogroups A, C, W-135 & Y conjugate vaccine
Indications/Uses
Active immunisation of individuals from 6 wk against invasive meningococcal diseases caused by Neisseria meningitidis serogroups A, C, W-135 & Y.
Dosage/Direction for Use
IM Primary immunisation Infant from 6 wk to <6 wk mth 2 doses 0.5 mL each w/ 1st dose given from 6 wk w/ 2 mth interval between doses. Unvaccinated infant from 6 mth to <12 mth 0.5 mL dose given from 6 mth. Adult, adolescent & childn from 12 mth 0.5 mL single dose. Booster vaccination Infant from 6 mth to <6 mth Booster dose should be given at 12 mth after completion of primary immunisation course. Previously vaccinated infant from 6 mth to <12 mth Booster dose should be given at 12 mth w/ at least 2 mth interval after primary dose. Adult, adolescent & childn from 12 mth Booster dose is not routinely administered, however may be given to subject previously vaccinated w/ Nimenrix, other conjugated or plain polysaccharide meningococcal vaccines.
*The product images shown are for illustration purposes only and may not be an exact representation of the product.
